CRBP

Corbus Pharmaceuticals Holdings, Inc.

7.74

USD

-0.13

-1.71%

Sep 23, 15:59 UTC -4

Closed

After-Market

7.67

-0.08

-0.97%

CRBP Earnings Reports

Positive Surprise Ratio

CRBP beat 23 of 43 last estimates.

53%

Next Report

Date of Next Report

Nov 10, 2026

Estimate for Q3 26 (Revenue/ EPS)

$1.27M

-$1.23

Implied change from Q2 26 (Revenue/ EPS)

-32.04%

Implied change from Q3 25 (Revenue/ EPS)

-35.26%

Corbus Pharmaceuticals Holdings, Inc. earnings per share and revenue

On Aug 06, 2026, CRBP reported earnings of -1.81 USD per share (EPS) for Q2 26, missing the estimate of -1.28 USD, resulting in a -41.05% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.78% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 7 analysts forecast an EPS of -1.23 USD, with revenue projected to reach 1.27 million USD, implying an decrease of -32.04% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Champions Oncology, Inc.

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.01

Actual

-$0.03

Surprise

-194.12%

PharmaCyte Biotech, Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

Actual

-$0.54

Surprise

FAQ

What were Corbus Pharmaceuticals Holdings, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Corbus Pharmaceuticals Holdings, Inc. reported EPS of -$1.81, missing estimates by -41.05%, and revenue of $0.00, 0% as expectations.

How did the market react to Corbus Pharmaceuticals Holdings, Inc.'s Q2 2026 earnings?

The stock price moved up 1.78%, changed from $9.57 before the earnings release to $9.74 the day after.

When is Corbus Pharmaceuticals Holdings, Inc. expected to report next?

The next earning report is scheduled for Nov 10, 2026.

What are the forecasts for Corbus Pharmaceuticals Holdings, Inc.'s next earnings report?

Based on 7 analysts, Corbus Pharmaceuticals Holdings, Inc. is expected to report EPS of -$1.23 and revenue of $1.27M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.